Segment Information by Division

External sales

1,356.2

1,363.5

860.4

567.0

92.0

59.0

–

4,298.1

Internal sales

4.6

45.1

7.5

261.1

5.7

206.4

–530.4

–

Total sales

1,360.8

1,408.6

867.9

828.1

97.7

265.4

–530.4

4,298.1

EBIT

193.8

86.3

64.9

349.8

6.0

–51.7

–1.2

647.9

Write-downs and impairments/
write-ups

163.5
 

81.6
 

44.0
 

72.2
 

3.2
 

42.8
 

–
 

407.3
 

EBITDA

357.3

167.9

108.9

422.0

9.2

–8.9

–1.2

1,055.2

EBIT includes:
Income from investments in joint ventures and associates

–22.4

 

–11.0

 

–

 

1.3

 

–

 

–1.6

 

–

 

–33.7

 

Impairment losses

–22.2

–

–8.0

–

–

–

–

–30.2

Additions to property, plant, and equipment¹

139.2
 

80.8
 

74.4
 

410.3
 

16.5
 

105.2
 

–
 

826.4
 

Additions to financial assets²

60.4

26.2

–

–

–

3.3

–

89.9

Asset additions

199.6

107.0

74.4

410.3

16.5

108.5

–

916.3

Assets (Dec. 31)

1,371.4

1,007.4

456.0

1,126.4

66.3

873.3

–275.7

4,625.1

Liabilities (Dec. 31)

394.7

413.6

151.6

1,175.9

22.5

637.4

–253.4

2,542.3

Net assets (Dec. 31)

976.7

593.8

304.4

–49.5

43.8

235.9

–22.3

2,082.8

Investments in joint ventures and associates included in net assets (Dec. 31)

114.2

 

43.6

 

–

 

34.0

 

–

 

–

 

–

 

191.8

 

Research and development expenses

–67.7
 

–31.5
 

–15.0
 

–5.4
 

–2.3
 

–41.3
 

–
 

–163.2
 

Employees (Dec. 31)

5,469

3,927

1,579

1,289

259

3,399

–

15,922

Employees (average)

5,566

3,923

1,561

1,156

255

3,337

–

15,798

2007

€ million

Siltronic

Silicones

Polymers

Polysilicon

Fine
Chemicals

Other

Consoli-
dation

Group

External sales

1,445.1

1,313.6

623.7

243.8

100.6

54.5

–

3,781.3

Internal sales

6.5

47.4

9.1

213.1

11.8

192.7

–480.6

–

Total sales

1,451.6

1,361.0

632.8

456.9

112.4

247.2

–480.6

3,781.3

EBIT

337.2

144.6

80.5

135.0

–7.5

–40.2

–

649.6

Write-downs and impairments/
write-ups

140.9
 

82.3
 

26.5
 

47.2
 

17.0
 

38.0
 

–
 

351.9
 

EBITDA

478.1

226.9

107.0

182.2

9.5

–2.2

–

1,001.5

EBIT includes: Income from investments in joint ventures and associates

–7.2

 

–3.7

 

–

 

1.5

 

–

 

0.1

 

–

 

–9.3

 

Impairment losses

–2.5

–0.1

–8.9

–

–12.5

–0.7

–

–24.7

Additions to property, plant, and equipment¹

118.4
 

100.7
 

41.0
 

228.3
 

7.5
 

82.6
 

–
 

578.5
 

Additions to financial assets²

81.6

1.5

–

31.2

–

6.5

–

120.8

Asset additions

200.0

102.2

41.0

259.5

7.5

89.1

–

699.3

Assets (Dec. 31)

1,230.6

973.0

255.3

618.9

52.3

875.2

–87.2

3,918.1

Liabilities (Dec. 31)

354.9

325.9

80.7

767.7

18.6

578.8

–74.1

2,052.5

Net assets (Dec. 31)

875.7

647.1

174.6

–148.8

33.7

296.4

–13.1

1,865.6

Investments in joint ventures and associates included in net assets (Dec. 31)

134.6

 

23.3

 

–

 

32.7

 

–

 

5.6

 

–

 

196.2

 

Research and development expenses

–63.9

–35.9

–7.6

–6.3

–2.1

–36.7

–

–152.5

Employees (Dec. 31)

5,634

3,871

1,128

1,003

245

3,163

–

15,044

Employees (average)

5,628

3,828

1,095

953

279

3,143

–

14,926